SolveBio
SolveBio

SolveBio Information

Contact top employees from SolveBio

Summary

SolveBio is a private company that has been in the industry for 12 years. The company currently specializes in the Information Technology and Services, IT Services areas. The position of the Founder & CEO is occupied by Mark Kaganovich. Its headquarters is located at New York, New York, USA. The number of employees ranges from 1 to 25. The annual revenue of SolveBio varies between 100K and 5.0M. Total funding of the company - $2.1M. To connect with SolveBio employee register on SignalHire.

Organization Website

solvebio.com

Social Links

facebooklinkedIntwitter

Industries

Headquarters Location

285 West Broadway, New York, NY, 10013 US

Employees Size

10-50 employees

SIC Code

7371

DMA Code

New York Metropolitan Area

Founded

2013

Estimated Annual Revenue

$100K - 5.0M

Operating Status

Independent Company

Competitors

Founded
Type
Employees
Revenue
Funding
2008Privately
Held
25 - 100 14.2M $89.1M
2011Privately
Held
100 - 250 225.1M $220.1M
2012Privately
Held
25 - 100 < 1M $8.5M
2011Privately
Held
100 - 250 82.5M $203.6M

Employees Turnover 3 quarter 2025

Length of Employment
arrow
Employee tenure at SolveBio shows a diverse range of experience levels:
14% for 3–4 years29% for 5–7 years29% for 8–10 years29% have over 11 years of service at SolveBio
Contact top employees from SolveBio
Bobby Touran
Advisor, Product & Commercial Development
View
Chad Malone
Advisor Strategy & Commercial Operations
View
David Park
Computer Systems Analyst
View
Sarah Brooks
Data Specialist Contractor
View
Tatjana Damnjanović
Software Engineer
View

FAQ

SolveBio operates in the IT Services industries. More details can be found on the official website: solvebio.com.
The headquarters of SolveBio are located in New York, United States.
The current CEO of SolveBio is Mark Kaganovich
SolveBio currently employs 10-50 people.
SolveBio's revenue is approximately < 1M.
Well-known competitors of SolveBio include Applied StemCell, Translate Bio, A Sanofi Company, Tute Genomics and Personalis, Inc..
BACK TO TOP